Yatsen Holding Limited reported a robust 47.5% year-over-year growth in total net revenues for Q3 2025, marking its fourth consecutive quarter of revenue growth and significantly narrowing its net loss margin.

• Skincare brands experienced exceptional growth of 83.2%, accounting for 49.2% of total revenue, underscoring a successful category upgrade strategy.
• The net loss margin improved from 17.9% to 7%, reflecting enhanced gross margins and operational efficiencies.
• Continued emphasis on innovation led to successful product launches and increased customer engagement, particularly in the Galani and Doctor Wu brands.
• Yatsen remains focused on disciplined capital allocation while driving profitability through a balanced growth strategy in its brand portfolio.